Searching Content indexed under Consumer Protection by LexOrbis ordered by Published Date Descending.
Links to Result pages
Celebrity Endorsement In The Consumer Protection Bill
People admire celebrities and if those celebrities say that they like a product then the admirer will like that particular product, too.
31 May 2017
Dettol’s Clean Sweep Deters Comparative Advertisement By Competitors
The world of Fast Moving Consumer Goods, thrives more often than not on their ability to advertise and make the product attractive to consumers at large, comparisons, puffing and praise being common to the exercise.
26 Jun 2013
Resurrection For Herbal Industry
Herbal medicine is considered as the medicine of the masses and is usually referred as ‘nature medicine’. The U.S. Food and Drug Administration (FDA) has for the first time approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV).
10 Apr 2007
Publici Juris – In Pharma Products
Publici juris" is a Latin word, and in the legal parlance, means, "of public right". The term signifies a thing or a right that is open and exercisable by all persons. It designates things that belong to the entire community, and not to any private party.
18 Dec 2006
Data Exclusivity & Patents Unrelated
The seven different forms of intellectual property rights stipulated in TRIPS are patents, copyrights, trademarks, industrial designs, geographical indications, protection of IC layout design and protection of undisclosed information. Each one is independent of each other and protects different aspects of an inventive work and extends different rights to the owner.
7 Nov 2006
Data Exclusivity – TRIPS Compliant or TRIPS Plus?
Intellectual Property as such gives a right to control the activities of others and this has a number of implications, which could give rise to issues resting on delicate grounds. The theory behind the patenting system is that the financial reward flowing from the exploitation of the patent and the disclosure of the resulting inventions for public dissemination and use, would encourage innovation and raise the technical level of a nation’s industry, at the same time contributing towards to its t
5 Sep 2006
Widening Ambit Of Indian Intellectual Property Regime
The Scenario in the IPR sector has undergone vibrant change in the recent past. This change has not been restricted to the pharmaceutical sector alone, but has extended itself to other systems of Intellectual Property.
13 Jul 2006
Scotch Whisky "Order" Prevails In India
Competition in the national and global markets has intensified bringing issues of identification and positioning to the forefront.
6 Jul 2006
Beyond Facade…
In the battle to acquire higher market shares, advertising and marketing strategies seem to play a key role.
6 Jul 2006
Product Patenting in the Indian Pharma Sector
In the recent times the Indian pharma sector has been marked by dynamic changes. The Patent Act of 1970 as amended on March 22, 2005 marked the end of a protected era and has brought in a new phase in the integration of India into the global pharmaceutical market.
14 Jun 2006
Distinctiveness through Secondary Meaning
Every trademark has a tendency to identify the goods sold under them as emanating from a particular source. This tendency with the efflux of time gets strengthened and a particular trademark gets registered or mentally associated in the minds of the consumers as distinctive of the product and its source. It can also be referred as ‘strength’ of the mark.
25 Apr 2006
"GLUCON-D" – Not An Exclusive Property
The Mark "GLUCON-D" was granted registration by the Indian Trade Marks Registry under registration No. 305664/30 on May 21, 1975 in relation to "Glucose (for food), Flour and Preparations Made from Cereals, Bread, Biscuits (Not for animals), Pastry and Confectionary (Non-Medicated), Milk Chocolate" in the name of Glaxo Laboratories (Indian) Limited.
23 Mar 2006
Links to Result pages